Acadian Asset Management LLC Aquestive Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.01 - $6.09 $34,003 - $103,024	-16,917 Reduced 3.07%	533,567 $2.27 Million
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.24 $582,025 - $869,158	388,017 Added 238.83%	550,484 $841,000
Q2 2023 Aug 07, 2023	BUY	$1.06 - $2.49 $172,215 - $404,542	162,467 New	162,467 $267,000
Q4 2019 Feb 06, 2020	SELL	$3.06 - $8.78 $58,415 - $167,610	-19,090 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$3.04 - $4.91 $58,033 - $93,731	19,090 New	19,090 $61,000
Q2 2019 Aug 08, 2019	SELL	$3.72 - $6.95 $35,061 - $65,503	-9,425 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$5.74 - $8.05 $54,099 - $75,871	9,425 New	9,425 $65,000

121

46.7M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $163M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.